Stay updated on Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial

Sign up to get notified when there's something new on the Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the frequency of motor seizures for participants with Dup15q or CDD in the study involving soticlestat.
    Difference
    0.1%
    Check dated 2024-06-06T14:36:36.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria 6' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing a more detailed explanation of eligibility criteria and examples such as general health condition or prior treatments. Additionally, specific inclusion and exclusion criteria for the study have been outlined.
    Difference
    10%
    Check dated 2024-05-22T21:35:03.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:14:37.000Z thumbnail image

Stay in the know with updates to Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial page.